5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.46▼ | 2.48▼ | 2.47▼ | 2.44▲ | 2.23▲ |
MA10 | 2.48▼ | 2.47▼ | 2.51▼ | 2.38▲ | 2.57▼ |
MA20 | 2.48▼ | 2.50▼ | 2.44▲ | 2.27▲ | 2.96▼ |
MA50 | 2.50▼ | 2.42▲ | 2.43▲ | 2.64▼ | 3.99▼ |
MA100 | 2.45▼ | 2.42▲ | 2.28▲ | 3.09▼ | 4.35▼ |
MA200 | 2.41▲ | 2.26▲ | 2.41▲ | 3.86▼ | 5.24▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.009▼ | -0.003▼ | 0.060▲ | -0.036▼ |
RSI | 37.444▼ | 47.906▼ | 50.884▲ | 50.229▲ | 36.396▼ |
STOCH | 6.250▼ | 32.619 | 33.937 | 71.258 | 22.120 |
WILL %R | -100.000▼ | -100.000▼ | -59.322 | -26.471 | -68.718 |
CCI | -141.795▼ | -64.859 | -10.707 | 83.300 | -58.417 |
RSI | $ACHV RSI(14) Crossed Above 50 | Set Alert |
Monday, April 21, 2025 08:31 AM
SEATTLE and VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global ...
|
Monday, April 21, 2025 08:18 AM
ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission ...
|
Friday, April 11, 2025 12:52 PM
Rick Stewart, Chief Executive Officer of Achiev SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 2.58 | 2.60 | 2.445 | 2.45 | 133,699 |
30/04/25 | 2.38 | 2.63 | 2.33 | 2.60 | 220,053 |
29/04/25 | 2.42 | 2.435 | 2.33 | 2.42 | 75,740 |
28/04/25 | 2.38 | 2.48 | 2.325 | 2.38 | 192,182 |
25/04/25 | 2.39 | 2.48 | 2.36 | 2.36 | 262,010 |
24/04/25 | 2.45 | 2.49 | 2.365 | 2.40 | 167,269 |
23/04/25 | 2.54 | 2.63 | 2.41 | 2.43 | 338,626 |
22/04/25 | 2.30 | 2.50 | 2.2802 | 2.48 | 215,086 |
21/04/25 | 1.98 | 2.27 | 1.96 | 2.25 | 318,234 |
17/04/25 | 2.10 | 2.135 | 1.95 | 1.99 | 260,173 |
|
|
||||
|
|
||||
|
|